Pharmaceuticals
Company Overview of Edge Therapeutics, Inc.
Company Overview
Edge Therapeutics, Inc., a hospital-focused biopharmaceutical company, designs and develops implantable technology for direct delivery of therapeutic compounds to the site of brain injury. Its drugs cover therapeutic areas, such as spontaneous brain hemorrhage, traumatic brain injuries, and brain surgeries. The company develops NimoGel and NimoVent to prevent delayed cerebral ischemia, a catastrophic delayed complication after subarachnoid hemorrhage. Its therapeutics are delivered to patients in the United States and internationally. The company was founded in 2009 and is based in Newark, New Jersey.
211 Warren Street
Newark, NJ 07103
United States
Founded in 2009
Key Executives for Edge Therapeutics, Inc.
Edge Therapeutics, Inc. Key Developments
Edge Therapeutics, Inc. announced the appointment of Isaac Blech as Vice Chairman of its Board of Directors. Separately, the company announced that Sol J. Barer, Ph.D., who has served on the Board since 2011, will become chairman effective January 1, 2013. At Celgene Corporation [CELG], he spent 18 years leading Celgene as president, COO and CEO, culminating with his tenure as Celgene's executive chairman and chairman before retiring in June 2011.
Edge Therapeutics, Inc. announced the appointment of Robert S. Langer, Ph.D., to chair its newly developed Scientific Advisory Committee. Dr. Langer is the David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT). He is the author of more than 1,100 journal articles and the most cited engineer in history.
Edge Therapeutics, Inc. Presents at 3rd Annual OneMedForum NY 2012, Jul-12-2012 11:50 AM. Venue: The Metropolitan Club, One East 60th Street, New York, NY 10022, United States.
Similar Private Companies By Industry
| Company Name | Region |
| Matrixx Initiatives, Inc. | United States |
| Javelin Pharmaceuticals, Inc. | United States |
| Synapsin Pharmaceuticals, Inc. | United States |
| Sierra Radiopharmacy LLC | United States |
| Kineta, Inc. | United States |
Recent Private Companies Transactions
| Type Date |
Target |
|
Private Placement
March 18, 2013 |
-- |
|
Private Placement
August 31, 2012 |
-- |
Most Searched Private Companies
| Company Name | Geographic Region |
| NYC2012, Inc. | United States |
| Bertelsmann AG | Europe |
| Lawyers Committee for Civil Rights Under Law | United States |
| Rush University | United States |
| Citizens Budget Commission | United States |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Stockton, CA | AstraZenecaPosted: May 20
- Princeton, NJ | RGPPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact Edge Therapeutics, Inc., please visit www.edgetherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
